TSO now 1M more (now stands at 205,425,875)So some (or someone) converted their (its) warrants for 250K shares, on top of the 750K by Roger and Kristina.
TSO now stands at 205,425,875, up 1M$.
Fully diluted, TLT shares stand at 286M shares. Not bad at all.
ImmunityBio has 14K$ revenues last Q1, has 688 employees and has a 1.4B$US market valuation (highest was 15B$US, avg over the last 1y is 3-5B$US) and ImmunityBio’s clinical pipeline consists of 27 clinical trials—18 of which are in Phase 2 or 3 development—across 13 indications in liquid and solid tumors (including bladder, pancreatic, and lung cancers) and infectious diseases (including SARS-CoV-2 and HIV).